Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083459 · ClinicalTrials.gov registry record

Impact of PCV on Disease and Colonization Among Native American Communities

A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
6,628
Enrollment target

NCT01083459 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 6,628 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083459 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
6,628 participants
Enrollment target

Study Summary

The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.

Trial Details

FieldValue
Enrollment Target 6,628 participants
Start Date 2010-01
Est. Completion 2012-04

What the Registry Record Tells You About NCT01083459

The ClinicalTrials.gov registry entry for NCT01083459 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,628 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01083459 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01083459 about?

NCT01083459 is a clinical study titled "Impact of PCV on Disease and Colonization Among Native American Communities". The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.

What is the current status of trial NCT01083459?

This trial is currently completed. The enrollment target is 6,628 participants. The study started on 2010-01. Estimated completion is 2012-04.

Who is sponsoring clinical trial NCT01083459?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.